Invivyd, Inc. — Investor Relations & Filings
Filings indexed
404
across all filing types
Latest filing
2026-05-19
Regulatory Filings
Country
US
United States of America
Listing
US
IVVD
Invivyd, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for serious viral infectious diseases. The company's mission is to rapidly and continually deliver therapies that keep pace with evolving viral threats. Utilizing a proprietary technology platform, Invivyd develops monoclonal antibody candidates designed to be more potent and resistant to virus evolution than the human immune system. Its pipeline is initially focused on addressing SARS-CoV-2, with plans to expand into other high-need indications such as influenza.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-19 | English | |
| S-8 | 2026-05-14 | English | |
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| 8-K - Invivyd, Inc. (0001832038) (Filer) | 2026-04-09 | English | |
| ARS - Invivyd, Inc. (0001832038) (Filer) | 2026-04-06 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46556161 | 8-K | 2026-05-19 | English | ||
| 46302527 | S-8 | 2026-05-14 | English | ||
| 45969270 | 10-Q | 2026-05-14 | English | ||
| 45969177 | 8-K | 2026-05-14 | English | ||
| 33903834 | 8-K - Invivyd, Inc. (0001832038) (Filer) | 2026-04-09 | English | ||
| 33642027 | ARS - Invivyd, Inc. (0001832038) (Filer) | 2026-04-06 | English | ||
| 33641027 | DEF 14A - Invivyd, Inc. (0001832038) (Filer) | 2026-04-06 | English | ||
| 32899403 | 4 - INVIVYD, INC. (0001832038) (Filer) | 2026-02-19 | English | ||
| 32899402 | 4 - INVIVYD, INC. (0001832038) (Filer) | 2026-02-19 | English | ||
| 32899404 | 4 - INVIVYD, INC. (0001832038) (Filer) | 2026-02-19 | English | ||
| 32899405 | 4 - INVIVYD, INC. (0001832038) (Filer) | 2026-02-19 | English | ||
| 32899406 | 4 - INVIVYD, INC. (0001832038) (Filer) | 2026-02-19 | English | ||
| 31974093 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31974079 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31974064 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-onc…
|
ATORX | SE | Manufacturing |
|
Allmed Medical Products Co., Ltd
Manufacturer of medical dressings, surgical kits, and dispo…
|
002950 | CN | Manufacturing |
|
Allogene Therapeutics, Inc.
Develops off-the-shelf allogeneic CAR T therapies for cance…
|
ALLO | US | Manufacturing |
|
Almirall S.A.
Global biopharmaceutical company specializing in medical de…
|
ALM | ES | Manufacturing |
|
ALNYLAM PHARMACEUTICALS, INC.
A biopharmaceutical company developing RNA interference (RN…
|
ALNY | US | Manufacturing |
|
Alpa Laboratories Limited
WHO-GMP certified manufacturer of human and veterinary phar…
|
ALPA | IN | Manufacturing |
|
Alpha Cognition Inc.
A biopharmaceutical company developing treatments for neuro…
|
ACOG | CA | Manufacturing |
|
Alphamab Oncology
Innovative biopharma specializing in differentiated anti-tu…
|
9966 | KY | Manufacturing |
|
Alpha Teknova, Inc.
Manufacturer of critical reagents for the life sciences ind…
|
TKNO | US | Manufacturing |
|
ALTERITY THERAPEUTICS LTD
A clinical-stage biotech developing novel treatments for ne…
|
ATHE | US | Manufacturing |
Invivyd, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33564/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33564 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33564 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33564 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33564}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Invivyd, Inc. (id: 33564)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.